Head-to-head · free
Sabra Healthcare REIT vs SDST
SBRA vs SDST — return on capital, cash generation, margins and balance sheet side by side.
SBRA
1 / 2
measures where SBRA leads
SDST
1 / 2
measures where SDST leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SBRA · FY2025 | SDST · FY2025 |
|---|---|---|
| Revenue | $774.6M | — |
| Net income | $155.6M | (15.7M) |
| Revenue growth (yearly, multi-year) | 8.0% | — |
| Free cash flow | — | (8.3M) |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | 4.8% | — |
| Return on equity | 5.6% | — |
| Gross margin | 65.0% | — |
| Operating margin | 34.1% | — |
| Net debt / EBITDA | 5.55x | 0.01x |
Figures are as reported by each company; latest fiscal year shown.
Where Sabra Healthcare REIT's cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where SDST's cash went (FY2025)
- Capital spending
- $4490
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free